• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU454520J
Device Problem Unintended Movement (3026)
Patient Problem Aneurysm (1708)
Event Date 11/15/2018
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: as gore was unable to determine which device was involved in the event if any, additional device(s) implanted include: tgu343415j/lot number unknown, no udi available.According to the instructions for use (ifu) for the gore® tag® thoracic endoprosthesis; adverse events that may occur include, but are not limited to include: endoleak, endoprosthesis: migration a review of the manufacturing records for the device(s) was unable to be conducted as the lot number(s) were unavailable.
 
Event Description
On (b)(6) 2018, this patient underwent endovascular treatment for a thoracic aortic aneurysm pending rupture, and was implanted with conformable gore® tag® thoracic endoprostheses and an axillary-axillary artery bypass and one debranch was performed.At the conclusion of the procedure a proximal type i endoleak persisted.The patient tolerated the procedure and declined additional treatment for the endoleak and will undergo monitoring by the physician.On an unknown date, a follow-up examination revealed possible aneurysm enlargement.On (b)(6) 2019, follow-up computed tomography determined enlargement of the aneurysm (amount unknown).The physician reported at this time that the proximal type i endoleak persisted, the device had migrated distally (distance unknown).On (b)(6) 2019, the patient underwent reintervention and the left common carotid artery (lcca)was bypassed and tethered to the original axillary-axillary artery bypass.A gore® excluder® internal iliac branch component was then implanted within the brachiocephalic artery using a chimney technique and both the lcca and brachiocephalic artery were intentionally covered with a additional conformable gore® tag® thoracic endoprostheses.The patient tolerated the procedure and the endoleak was resolved.
 
Manufacturer Narrative
D11: as gore was unable to determine which device was involved in the event if any; additional device(s) implanted include: tgu343415j/17900217, udi: (b)(4).H6: code 213 further investigation returned the lot numbers for the devices involved in this event, a review of the manufacturing records for the devices verified that the lots met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8392186
MDR Text Key137881949
Report Number2017233-2019-00125
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/13/2020
Device Catalogue NumberTGU454520J
Device Lot Number17310223
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/05/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age62 YR
-
-